drugset / Trial / NCT00851162

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

NCT00851162 ↗

Phase 2/3 Withdrawn Emory University
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether using mesenchymal stem cells will heal benign bone lesion defects faster than demineralized bone matrix

Timeline

Start
2009-03
Primary completion
2010-03
Completion
2010-03

Outcome

Outcome not reported

Stopped (Enrollment): “Study was not continued due to lack of enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Demineralized Bone Matrix Other / unclassified — —
Subject Trinity Cell therapy — —

Indications